Bio-Thera Strengthens Ties With Pharmapark By Adding Ustekinumab

Follows Earlier License And Supply Agreement For Golimumab Biosimilar

Russia
Bio-Thera has signed another deal for its Stelara biosimilar • Source: Shutterstock

More from Biosimilars

More from Products